NO934282L - Calcium, trace metal, vitamin D and drug therapy combinations - Google Patents
Calcium, trace metal, vitamin D and drug therapy combinationsInfo
- Publication number
- NO934282L NO934282L NO934282A NO934282A NO934282L NO 934282 L NO934282 L NO 934282L NO 934282 A NO934282 A NO 934282A NO 934282 A NO934282 A NO 934282A NO 934282 L NO934282 L NO 934282L
- Authority
- NO
- Norway
- Prior art keywords
- supplements
- vitamin
- calcium
- drug therapy
- trace metal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Næringsmessige mineralsupplementer innbefattende kalsiumsitratmalat, salter av mangan, kobber og sink og en forbindelse eller forbindelser valgt fra gruppen vitamin D eller dets metabolitter eller prekursorer og medikamentterapeutika omfattende kalsitonin, editro- nat, difosfonater og amino-difosfonater er beskrevet. Østrogen kan også bli brukt med disse supplementer. Disse supplementer som gir minst 25 % RAD av kal- siummet, spormineraler og vitaminer, blir brukt i tillegg til den normale kost. Disse supplementer er anvendelige for å oke benvekst og for å behandle alders-relatert bentap hos mennesker og dyr. Sup- plementene kan være i form av fast tabletter, flytende enhetsdoseringsformer, eller i en drikkevare.Nutritional mineral supplements including calcium citrate malate, manganese, copper and zinc salts and a compound or compounds selected from the group of vitamin D or its metabolites or precursors and drug therapeutics comprising calcitonin, editronate, diphosphonates and amino diphosphonates are disclosed. Estrogen can also be used with these supplements. These supplements that provide at least 25% RAD of the calcium, trace minerals and vitamins are used in addition to the normal diet. These supplements are useful for increasing bone growth and for treating age-related bone loss in humans and animals. The supplements may be in the form of solid tablets, liquid unit dosage forms, or in a beverage.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70583291A | 1991-05-28 | 1991-05-28 | |
PCT/US1992/003995 WO1992021355A1 (en) | 1991-05-28 | 1992-05-15 | Calcium, trace mineral, vitamin d and drug therapy combinations |
Publications (2)
Publication Number | Publication Date |
---|---|
NO934282D0 NO934282D0 (en) | 1993-11-26 |
NO934282L true NO934282L (en) | 1994-01-28 |
Family
ID=24835140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO934282A NO934282L (en) | 1991-05-28 | 1993-11-26 | Calcium, trace metal, vitamin D and drug therapy combinations |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0586521A1 (en) |
JP (1) | JPH07502012A (en) |
KR (1) | KR100244603B1 (en) |
AU (1) | AU666654B2 (en) |
BR (1) | BR9206072A (en) |
CA (1) | CA2109958C (en) |
CZ (1) | CZ281823B6 (en) |
HU (1) | HUT66379A (en) |
IE (1) | IE921701A1 (en) |
NO (1) | NO934282L (en) |
NZ (1) | NZ242920A (en) |
SK (1) | SK132693A3 (en) |
WO (1) | WO1992021355A1 (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5674844A (en) * | 1991-03-11 | 1997-10-07 | Creative Biomolecules, Inc. | Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
US7056882B2 (en) | 1991-03-11 | 2006-06-06 | Curis, Inc. | Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
EP0600834A1 (en) * | 1992-11-30 | 1994-06-08 | Ciba-Geigy Ag | Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing |
AU670337B2 (en) | 1992-11-30 | 1996-07-11 | Novartis Ag | Use of certain methanebisphosphonic acid derivatives in fracture healing |
FR2704393B1 (en) * | 1993-04-30 | 1995-06-02 | Boiron | Absorbable nutritional supplement to optimize growth and maintain strong bones. |
US5763429A (en) * | 1993-09-10 | 1998-06-09 | Bone Care International, Inc. | Method of treating prostatic diseases using active vitamin D analogues |
FR2723682B1 (en) * | 1994-08-19 | 1996-09-27 | Boiron | ABSORBABLE NUTRITIONAL SUPPLEMENT FOR THE DAILY BALANCE OF CHILDREN AND ADOLESCENTS. |
IL115241A (en) * | 1994-09-26 | 2000-08-31 | American Cyanamid Co | Calcium dietary supplement |
DE19503190A1 (en) * | 1995-02-01 | 1996-08-08 | Dietl Hans | Means for influencing disorders of bone formation |
US5609897A (en) * | 1995-04-07 | 1997-03-11 | Abbott Laboratories | Powdered beverage concentrate or additive fortified with calcium and vitamin D |
US5597595A (en) * | 1995-04-07 | 1997-01-28 | Abbott Laboratories | Low pH beverage fortified with calcium and vitamin D |
US5698222A (en) * | 1995-04-07 | 1997-12-16 | Abbott Laboratories | Calcium supplement |
US5817351A (en) * | 1995-04-07 | 1998-10-06 | Abbott Laboratories | Calcium fortified low pH beverage |
CA2266098A1 (en) * | 1996-09-26 | 1998-04-02 | Oklahoma Medical Research Foundation | Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester and its derivatives in disease regression |
US6503893B2 (en) | 1996-12-30 | 2003-01-07 | Bone Care International, Inc. | Method of treating hyperproliferative diseases using active vitamin D analogues |
US6566353B2 (en) | 1996-12-30 | 2003-05-20 | Bone Care International, Inc. | Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
US6573256B2 (en) | 1996-12-30 | 2003-06-03 | Bone Care International, Inc. | Method of inhibiting angiogenesis using active vitamin D analogues |
US6929797B2 (en) * | 1997-02-13 | 2005-08-16 | Bone Care International, Inc. | Targeted therapeutic delivery of vitamin D compounds |
GB9703109D0 (en) * | 1997-02-14 | 1997-04-02 | Smith & Nephew | Compositions |
US6479474B2 (en) | 1999-07-08 | 2002-11-12 | Wisconsin Alumni Research Foundation | Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis |
ES2394782T3 (en) * | 2003-05-07 | 2013-02-05 | Osteologix A/S | Composition with strontium and vitamin D for the prophylaxis and / or treatment of cartilage and / or bone conditions |
WO2005072539A1 (en) * | 2004-01-28 | 2005-08-11 | Dr. Paul Lohmann Gmbh Kg | Method for the production of a calcium lactate malate compound and calcium lactate malate compound |
EP1796683A1 (en) * | 2004-07-15 | 2007-06-20 | Nanobac Life Sciences | Methods and compositions for the administration of calcium chelators, bisphosphonates and/or citrate compounds and their pharmaceutical uses |
US7473684B2 (en) * | 2005-09-16 | 2009-01-06 | Selamine Limited | Bisphosphonate formulation |
WO2007098092A2 (en) * | 2006-02-21 | 2007-08-30 | Nutrijoy, Inc. | Food and beverage products with improved taste impressions |
JP5619334B2 (en) * | 2006-06-14 | 2014-11-05 | 允聖 崔 | Bone strengthening agent |
US8889195B2 (en) * | 2006-08-17 | 2014-11-18 | The Procter & Gamble Company | Compositions comprising calcium citrate malate and methods for making the same |
CA2661062C (en) * | 2006-08-17 | 2012-08-14 | The Procter & Gamble Company | Compositions comprising calcium citrate malate and methods for making the same |
WO2009019307A2 (en) * | 2007-08-09 | 2009-02-12 | Novartis Ag | Oral calcitonin compositions and applications thereof |
HUE025737T2 (en) | 2009-09-01 | 2016-05-30 | Univ Duke | Bisphosphonate compositions and methods for treating heart failure |
CA2856030A1 (en) | 2011-11-16 | 2013-05-23 | Duke University | Bisphosphonate compositions and methods for treating and/or reducing cardiac dysfunction |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3992556A (en) * | 1973-05-07 | 1976-11-16 | Vitamins, Inc. | Supplemented food product |
GB8622025D0 (en) * | 1986-09-12 | 1986-10-22 | Beecham Group Plc | Composition |
FR2618305B1 (en) * | 1987-07-23 | 1989-10-27 | Synthelabo | NUTRITIONAL MIXTURE FOR THE ELDERLY |
JP2516794B2 (en) * | 1988-02-26 | 1996-07-24 | 雪印乳業株式会社 | Baby formula containing vitamin D metabolites |
EP0343703A3 (en) * | 1988-05-26 | 1990-06-06 | The Procter & Gamble Company | Mineral supplements with sugar alcohols |
US5151274A (en) * | 1990-08-06 | 1992-09-29 | The Procter & Gamble Company | Calcium and trace mineral supplements |
-
1992
- 1992-05-15 JP JP5500425A patent/JPH07502012A/en active Pending
- 1992-05-15 BR BR9206072A patent/BR9206072A/en not_active Application Discontinuation
- 1992-05-15 SK SK1326-93A patent/SK132693A3/en unknown
- 1992-05-15 EP EP92912201A patent/EP0586521A1/en not_active Withdrawn
- 1992-05-15 KR KR1019930703623A patent/KR100244603B1/en not_active IP Right Cessation
- 1992-05-15 CA CA002109958A patent/CA2109958C/en not_active Expired - Fee Related
- 1992-05-15 HU HU9303364A patent/HUT66379A/en unknown
- 1992-05-15 CZ CS932553A patent/CZ281823B6/en unknown
- 1992-05-15 AU AU19968/92A patent/AU666654B2/en not_active Ceased
- 1992-05-15 WO PCT/US1992/003995 patent/WO1992021355A1/en not_active Application Discontinuation
- 1992-05-27 NZ NZ242920A patent/NZ242920A/en unknown
- 1992-07-01 IE IE170192A patent/IE921701A1/en not_active Application Discontinuation
-
1993
- 1993-11-26 NO NO934282A patent/NO934282L/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR100244603B1 (en) | 2000-03-02 |
NZ242920A (en) | 1995-06-27 |
CZ281823B6 (en) | 1997-02-12 |
JPH07502012A (en) | 1995-03-02 |
CA2109958C (en) | 1997-06-10 |
HUT66379A (en) | 1994-11-28 |
IE921701A1 (en) | 1992-12-02 |
SK132693A3 (en) | 1994-06-08 |
WO1992021355A1 (en) | 1992-12-10 |
AU666654B2 (en) | 1996-02-22 |
CZ255393A3 (en) | 1994-07-13 |
BR9206072A (en) | 1994-11-15 |
HU9303364D0 (en) | 1994-03-28 |
AU1996892A (en) | 1993-01-08 |
NO934282D0 (en) | 1993-11-26 |
EP0586521A1 (en) | 1994-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO934282L (en) | Calcium, trace metal, vitamin D and drug therapy combinations | |
CA2102210A1 (en) | Combined Calcium and Vitamin D Supplements | |
MY107865A (en) | Calcium and trace mineral supplements. | |
CA2078019A1 (en) | Substance or composition and uses thereof | |
Burckhardt | The effect of the alkali load of mineral water on bone metabolism: interventional studies | |
Oberleas | Mechanism of zinc homeostasis | |
PT979224E (en) | SOLID COMPOUNDS SUITABLE FOR ORAL ADMINISTRATION COMPOSED BY L-CARNITINE OR MAGNESIUM ALCANOYL-L-CARNITINE | |
Leibholz | Arginine requirements of pigs between 7 and 28 days of age | |
AU2001275146A1 (en) | Compositions for enhancing therapeutic effects containing herbals and/or nutritional supplements and/or minerals and/or vitamins | |
PT971879E (en) | SOLID COMPOUNDS SUITABLE FOR ORAL ADMINISTRATION UNDERSTANDING L-CARNITINO AND ALCANOIL.L.CARNITINO MAGNESIUM TORTOISE | |
GB9718413D0 (en) | Compositions | |
Harkins et al. | Effect of NaF on the growth of rats with varying vitamin and calcium intakes | |
PT971880E (en) | SOLID COMPOUNDS SUITABLE FOR ORAL ADMINISTRATION UNDERSTANDING NON-HYDROSCOPIC SALTS OF L-CARNITINE AND ALCANOYL-L-CARNITINE WITH 2-AMINOETHANESULFONIC ACID | |
PT975581E (en) | SOLID COMPOUNDS SUITABLE FOR ORAL ADMINISTRATION COMPARING L-CARNITINE AND HYDROCARBON OR ALANO-L-CARNITINE AND HILL TARTARATE | |
Chiu | Efficacy of calcium supplements on bone mass in postmenopausal women. | |
DE69230341D1 (en) | MANUFACTURE OF FATTY ACID SALT DIET PRODUCTS | |
RU93058335A (en) | ADDITIVES CONTAINING CALCIUM AND VITAMIN D, DRINK | |
JPS63307816A (en) | Medicinal composition containing mixture of salts of keto acid and amino acid | |
Heaney | Calcium, bone, and life | |
Giglio et al. | Skeletal-unit growth in the mandible of rats given diphenylhydantoin | |
INPUTS | Robert P. Heaney, MD | |
Kerby et al. | Protein supplementation of stocker calves grazing Tifton 85 and Coastal bermudagrass | |
SK222991A3 (en) | Veterinary composition for treatment of digestion disorders of ruminants |